Profile: Neurosearch A/S (NEUR.CO)
NEUR.CO on Copenhagen Stock Exchange
Change (% chg)
Neurosearch A/S (NEUR) is Denmark-based biopharmaceutical company. It specializes in the research, development and sale of drug candidates. The Company’s portfolio comprises three products: Tesofensine, a drug used in obesity, which works as a monoamine reuptake inhibitor (MRI); Seridopidine, which is applied in central nervous system (CNS) diseases and acts as a dopaminergic stabilizer; and Ordopidine, a medicine, which also is involved in the CNS disease treatment as a dopaminergic stabilizer. Furthermore, the Company operates through three wholly owned subsidiaries, NeuroSearch Sweden AB, Poseidon Pharmaceutical A/S and NsExplorer A/S, as well as through affiliates, such as Atonomics A/S and NsGene A/S.